HomeHEAL • CNSX
add
Restart Life Sciences Corp
Previous close
$0.095
Year range
$0.030 - $0.18
Market cap
3.42M CAD
Avg Volume
18.31K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 156.52K | 86.05% |
Net income | -203.48K | -124.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -156.07K | -86.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 262.38K | 2,075.61% |
Total assets | 277.56K | 953.43% |
Total liabilities | 214.89K | -79.95% |
Total equity | 62.67K | — |
Shares outstanding | 36.05M | — |
Price to book | ∞ | — |
Return on assets | -113.12% | — |
Return on capital | -238.01% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -203.48K | -124.65% |
Cash from operations | -77.59K | -694.90% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -77.59K | -694.90% |
Free cash flow | -20.28K | -171.83% |
About
Founded
2004
Headquarters
Website
